Spyre Therapeutics, Inc. ($SYRE)
Fairmount Funds Management LLC โ Director
Shares
8,026
Price
$0.00
Total Value
$0.00
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Fairmount Funds Management LLC |
|---|---|
| Title | Director |
| Transaction Date | May 27, 2026 |
| Expiration Date | May 27, 2036 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Stock Option (Right to Buy) |
| Derivative | Yes |
| Direct/Indirect | Indirect |
| Nature of Ownership | By Tomas Kiselak |
| Filing Date | May 29, 2026 |
| Shares Purchased | 8,026 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 8,026 |
| Derivative | Derivative |
| Accession Number | 0001636282-26-000069 |
| Document | View SEC Filing |